CW April 2000Issue Number 4 April 2000 ISSN 10593802 Innovative Palliative Treatment for Advanced Prostate CancerA novel implant to supply a constant level of testosterone-suppressing drug to advanced prostate cancer patients is approved by the US Food and Drug Administration. Bayer Corporation based in Pittsburgh, PA will distribute the implant.
Go to Previous Page Go to Next Page Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW April 2000Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |